Tokio Marine Asset Management Co. Ltd. Increases Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Tokio Marine Asset Management Co. Ltd. raised its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,420 shares of the biopharmaceutical company’s stock after acquiring an additional 81 shares during […]

Related Keywords

Tokio ,Tokyo ,Japan ,Marion Mccourt ,Bonniel Bassler ,Eudaimonia Advisors ,Regeneron Pharmaceuticals Profile ,Sutton Wealth Advisors Inc ,Nasdaq ,Regeneron Pharmaceuticals ,Regeneron Pharmaceuticals Inc ,Cantor Fitzgerald ,Quarter For Regeneron Pharmaceuticals ,Clearview Wealth Advisors ,Exchange Commission ,Morgan Stanley ,Barclays ,Securities Exchange Commission ,Tokio Marine Asset Management Co ,Wealth Management ,News Ratings For Regeneron Pharmaceuticals Daily ,Regeneron Pharmaceuticals Stock Performance ,Tokio Marine Asset Management ,Free Report ,Marine Asset Management ,Wealth Advisors ,Director Bonnie ,Get Free Report ,Regeneron Pharmaceuticals Daily ,Nasdaq Regn ,Regn ,Medical ,75886f10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,